Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab
Crossref DOI link: https://doi.org/10.1186/s40425-016-0141-1
Published Online: 2016-06-21
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Retseck, Janet
VanderWeele, Robert
Lin, Hui-Min
Lin, Yan
Butterfield, Lisa H.
Tarhini, Ahmad A.
Funding for this research was provided by:
Bristol-Myers Squibb
National Institutes of Health (P50CA121973, P30CA047904)
